Kathryn Davis
Medical · Dallas, TXNPI 1326756446
Payments from drug & device makers
Across 142 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$433
- Lilly USA, LLC$176
- GSK$168
- Exact Sciences$150
- Axsome Therapeutics, Inc.$133
- Boehringer Ingelheim$133
- plus $2K from 28 others
What the payments were for
- Food & beverage$2,708100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $433 |
| Lilly USA, LLC | 11 | $176 |
| GSK | 9 | $168 |
| Exact Sciences | 8 | $150 |
| Axsome Therapeutics, Inc. | 6 | $133 |
| Boehringer Ingelheim | 6 | $133 |
| Novo Nordisk | 8 | $132 |
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| Cleerly, Inc. | 1 | $112 |
| Pfizer | 5 | $94 |
| Idorsia Pharmaceuticals US Inc | 6 | $84 |
| Dexcom, Inc. | 4 | $82 |
| Amgen | 4 | $82 |
| Seqirus USA Inc | 5 | $79 |
| Abiomed | 2 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $66 |
| Indivior Inc. | 3 | $64 |
| Viiv Healthcare Company | 2 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $57 |
| Astellas Pharma US Inc | 3 | $51 |
| AstraZeneca | 3 | $48 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Noven Therapeutics, LLC | 2 | $33 |
| Verity Pharmaceuticals Inc. | 1 | $30 |
| Corium, LLC | 1 | $29 |
| Teleflex LLC | 1 | $28 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Boston Scientific | 1 | $26 |
| Ardelyx, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $18 |
| Merck | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cleerly Ischemia$112
- Cleerly Labs$112
How this compares
$2,708 in reported general payments places this provider in the 70th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 20 | $521 |
| Zolpidem Tartrate | 59 | $383 |
| Temazepam | 27 | $229 |
| Cyclobenzaprine Hcl | 15 | $190 |
| Alprazolam | 44 | $179 |
| Clonazepam | 17 | $174 |
| Trazodone Hcl | 19 | $136 |
| Pantoprazole Sodium | 11 | $136 |
| Tramadol Hcl | 33 | $127 |
| Levothyroxine Sodium | 16 | $103 |
| Lorazepam | 12 | $94 |
| Lisinopril | 13 | $72 |
| Eszopiclone | 13 | $56 |
| Azithromycin | 20 | $44 |
| Atorvastatin Calcium | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.